Legal Opinion

Sarah Speed v. Wyeth Pharmaceuticals, Inc.

Court of Appeals for the Sixth Circuit

Decided December 2, 2013No. 12-6195, 12-6198, 12-6200, 12-6203, 12-6208, 12-6209, 12-6210PublishedCited by 76 opinions

1Opinion of the CourtGilman, J., joined by Griffin, J.,

STRANCH, J. (pp. 407-15), delivered a separate opinion concurring in part and dissenting in part.

OPINION

RONALD LEE GILMAN, Circuit Judge.

These seven consolidated cases are among the many that have been filed nationwide against the manufacturers of both the prescription drug Reglan and its generic equivalent, metoclopramide. The plaintiffs allege that they ingested generic metoclopramide and, as a result, developed a serious neurological disorder known as tardive dyskinesia. They filed suit against both the generic and brand-name manufacturers, alleging a wide variety of product-liability…

2Cases cited53 opinions

  1. Ashcroft v. IqbalSupreme Court of the United States · 2009
  2. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  3. Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
  4. Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
  5. Cipollone v. Liggett Group, Inc.Supreme Court of the United States · 1992

48 more not listed; retrieve them via the Exa API.

3Cited by76 opinions

  1. T.H. v. Novartis Pharmaceuticals CorporationCalifornia Supreme Court · 2017
  2. Yanise Germain v. Teva Pharmaceuticals, USA, IncCourt of Appeals for the Sixth Circuit · 2014
  3. United States Ex Rel. Harper v. Muskingum Watershed Conservancy DistrictCourt of Appeals for the Sixth Circuit · 2016
  4. Mirando v. United States Department of TreasuryCourt of Appeals for the Sixth Circuit · 2014
  5. In Re Fosamax (Alendronate Sodium) Products Liability LitigationCourt of Appeals for the Third Circuit · 2014

71 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API